ENTITY
Ascletis Pharma Inc

Ascletis Pharma Inc (1672 HK)

67
Analysis
Health CareChina
Ascletis Pharma Inc. operates as a biotechnology company. The Company develops and discovers anti-viral drugs to address unmet medical needs in anti-viral, cancer, and fatty liver disease. Ascletis Pharma offers its services worldwide.
more
bullishWuXi AppTec
21 Nov 2018 10:41

Wuxi Apptec 药明康德 IPO: Welcome to the A/H Universe

WuXi Apptec is set to be the newest A/H pair with its upcoming HK listing that is set to raise USD 1 billion. The A-share (603289 CH) recorded 15...

Share
bearishBabytree Group
19 Nov 2018 11:47

Last Week in GER Research: Babytree, NTT, Tongcheng, IDreamSky, Fosun, Sinochem, and Mogu

Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team. This week we highlight the latest on...

Logo
648 Views
Share
bearishSoftbank Group
12 Nov 2018 06:05

Last Week in GER Research: Softbank, Haidilao, Tongcheng-Elong, Ctrip and 360 Finance

Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team.  This week we update on Softbank Group (9984...

Logo
341 Views
Share
bearishSoftbank Group
05 Nov 2018 06:03

Last Week in GER Research: Softbank, Babytree, Tencent Music, MYOB, Yancoal, Spotify Warning & More!

Below is a recap of the key IPO and event-driven research produced by the Global Equity Research team.  Last week, Arun initiated IPO coverage...

Logo
312 Views
Share
01 Nov 2018 14:21

Innovent Biologics (信达生物) Post IPO: Hit Our TP, What's Next?

Innovent Biologics was priced at the high end and it started trading yesterday (November 1st). It traded up by 18.5% on the first day and 8% on the...

Logo
548 Views
Share
x